GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 61 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,737 | +33.3% | 37,884 | 0.0% | 0.00% | – |
| Q2 2023 | $54,553 | -31.4% | 37,884 | 0.0% | 0.00% | – |
| Q1 2023 | $79,556 | +85.8% | 37,884 | 0.0% | 0.00% | – |
| Q4 2022 | $42,809 | -36.1% | 37,884 | -7.3% | 0.00% | – |
| Q3 2022 | $67,000 | +24.1% | 40,884 | 0.0% | 0.00% | – |
| Q2 2022 | $54,000 | +28.6% | 40,884 | +280.1% | 0.00% | – |
| Q3 2021 | $42,000 | +23.5% | 10,756 | 0.0% | 0.00% | – |
| Q2 2021 | $34,000 | +47.8% | 10,756 | 0.0% | 0.00% | – |
| Q1 2021 | $23,000 | -4.2% | 10,756 | 0.0% | 0.00% | – |
| Q4 2020 | $24,000 | -17.2% | 10,756 | 0.0% | 0.00% | – |
| Q3 2020 | $29,000 | -12.1% | 10,756 | 0.0% | 0.00% | – |
| Q2 2020 | $33,000 | +57.1% | 10,756 | 0.0% | 0.00% | – |
| Q1 2020 | $21,000 | -78.6% | 10,756 | -68.5% | 0.00% | -100.0% |
| Q4 2019 | $98,000 | -21.6% | 34,120 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $125,000 | +177.8% | 34,120 | +217.2% | 0.00% | – |
| Q2 2019 | $45,000 | – | 10,756 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 169,578 | $222,000 | 0.08% |
| Geneos Wealth Management Inc. | 478,067 | $626,000 | 0.03% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $16,000 | 0.01% |
| Atria Wealth Solutions, Inc. | 281,700 | $369,000 | 0.01% |
| Vivaldi Capital Management LP | 17,078 | $22,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,284,481 | $1,684,000 | 0.00% |
| Ameritas Advisory Services, LLC | 45,302 | $59,000 | 0.00% |
| CENTAURUS FINANCIAL, INC. | 20,947 | $27,000 | 0.00% |
| Summit Trail Advisors, LLC | 23,855 | $31,000 | 0.00% |
| WEDBUSH SECURITIES INC | 27,998 | $37,000 | 0.00% |